Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

32621 - 32630 of 44979 results found

Glucose-6-phosphate dehydrogenase (G6PD) Deficiency and COVID-19

Date
Wednesday, June 07, 2023 - 4:00 AM
Description
In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency have an increased risk of COVID-19 infection and severity, with higher rates of

Broadly neutralizing antibodies against COVID-19

Date
Wednesday, June 07, 2023 - 4:00 AM
Description
The COVID-19 pandemic caused by SARS-CoV-2 has led to hundreds of millions of infections and millions of deaths, however, human monoclonal antibodies (mAbs) can be an effective treatment. Since SARS-CoV-2 emerged, a variety of strains have acquired

Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England

Date
Wednesday, June 07, 2023 - 4:00 AM
Description
CONCLUSIONS: We observed an increased risk of myocarditis within the first week after priming and booster doses of mRNA vaccines, predominantly in males under 40 years with the highest risks after a second dose. The risk difference between the second